Background/objective (s) Psychotropic medications are commonly prescribed among adults
with intellectual disability, often in the absence of a psychiatric diagnosis. The aim of this …

A review on the mental health needs of adults with intellectual disability (ID) and autism
spectrum disorder (ASD) published just over 10 years ago found a limited evidence base for …

On average, 49–63% of people with intellectual disabilities and/or autism spectrum disorder
(ASD) are prescribed psychotropic medications to treat psychopathology, including …

The prescribing of psychotropic medications for people with an intellectual disability has
changed. In many locations across England, antidepressants have become the most widely …

Purpose People with intellectual disabilities (ID) suffer multimorbidity, polypharmacy and
excess mortality at a younger age than general population. Those with ID and epilepsy are …

Background There is evidence that psychotropic medications are overprescribed and
overused to manage behaviours of concern for people with intellectual disabilities. Disability …

People with intellectual disabilities (PwID) are at a higher risk of developing challenging
behaviours (CB). Despite the poor evidence for the effectiveness of medications in …

International current best practice recommends the discontinuation of antipsychotics for
challenging behaviours in people with intellectual disabilities (ID), due to lack of evidence of …

Background Around 25% of people with Intellectual Disability (PwID) have comorbid
epilepsy with seizures in up to two-thirds being drug-resistant. Little is known of the general …

Background Overmedication of people with intellectual disabilities, particularly when
psychotropic medications are used for challenging behavior (CB) in the absence of a …